Royal Bank of Canada’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $255K | Sell |
|
|||||
|
2025
Q2 | $265K | Buy |
|
|||||
|
2025
Q1 | $256K | Buy |
|
|||||
|
2024
Q4 | $199K | Sell |
|
|||||
|
2024
Q3 | $217K | Sell |
|
|||||
|
2024
Q2 | $327K | Sell |
|
|||||
|
2024
Q1 | $284K | Buy |
|
|||||
|
2023
Q4 | $164K | Sell |
|
|||||
|
2023
Q3 | $319K | Sell |
|
|||||
|
2023
Q2 | $498K | Buy |
|
|||||
|
2023
Q1 | $467K | Buy |
|
|||||
|
2022
Q4 | $160K | Buy |
|
|||||
|
2022
Q3 | $210K | Buy |
|
|||||
|
2022
Q2 | $229K | Buy |
|
|||||
|
2022
Q1 | $236K | Sell |
|
|||||
|
2021
Q4 | $340K | Sell |
|
|||||
|
2021
Q3 | $372K | Buy |
|
|||||
|
2021
Q2 | $451K | Buy |
|
|||||
|
2021
Q1 | $314K | Sell |
|
|||||
|
2020
Q4 | $487K | Sell |
|
|||||
|
2020
Q3 | $393K | Buy |
|
|||||
|
2020
Q2 | $411K | Buy |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $31K | Buy |
|
|||||
|
2019
Q3 | $23K | Sell |
|
|||||
|
2019
Q2 | $27K | Sell |
|
|||||
|
2019
Q1 | $35K | Sell |
|
|||||
|
2018
Q4 | $74K | Buy |
|
|||||
|
2018
Q3 | $62K | Buy |
|
|||||
|
2018
Q2 | $50K | Sell |
|
|||||
|
2018
Q1 | $61K | Sell |
|
|||||
|
2017
Q4 | $59K | Sell |
|
|||||
|
2017
Q3 | $129K | Buy |
|
|||||
|
2017
Q2 | $57K | Buy |
|
|||||
|
2017
Q1 | $49K | Sell |
|
|||||
|
2016
Q4 | $75K | Buy |
|
|||||
|
2016
Q3 | $58K | Buy |
|
|||||
|
2016
Q2 | $28K | Sell |
|
|||||
|
2016
Q1 | $87K | Sell |
|
|||||
|
2015
Q4 | $97K | Sell |
|
|||||
|
2015
Q3 | $142K | Buy |
|
|||||
|
2015
Q2 | $92K | Sell |
|
|||||
|
2015
Q1 | $79K | Hold |
|
|||||
|
2014
Q4 | $122K | Buy |
|
|||||
|
2014
Q3 | $83K | Hold |
|
|||||
|
2014
Q2 | $129K | Buy |
|
|||||
|
2014
Q1 | $44K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $734K | Buy |
|
|||||
|
2013
Q2 | $336K | Buy |
|